Quote:
Originally Posted by PhoenixResurrection As u said, I would prefer to wait before rushing into such new vaccines...
I still remember the hepatitis B vaccine and the associated adverse reactions (inc. multiple sclerosis). |
I agree. So far the side effects from HPV vaccine are very minimal, even relative to other vaccines. Studies have been ongoing for at least 6 years so far.
On HBV, a few studies did suggest such a link, but so far investigations into it have turned this idea out. The WHO vaccine safety committee concluded there is no causal link. Most authorities do not suggest a link. But yeah the picture's not as clear as one would like I guess.
Quote:
Originally Posted by Rors Good, the price dropped a bit, it was around 450 $ when it first came out.
The thing is you're gonna pay 300$ to get a vaccine that will not cover you 100%. It is true that HPV 16 and 18 are the most common and widespread, but there is still a risk of 30% of infection with other subtypes (boy are those numerous), and 300$ is huge a cost for such an elevated residual risk.
If people can afford it, why not, it IS minimising the chance of getting cervical cancer by 70%., and so far i haven't heard of any reports of severe undesirable side effects. I can get more accurate details later on. |
Yeah I think it's a pretty good investment, even if it covers 70%...I mean, better that than a new stereo or purse. Of course I agree if it's going to cost someone relatively a lot, then definitely the money's better spent somewhere else...
the last thing people should do is get crazy over the vaccine ... especially in Lebanon bi seer ekher mouda hehe.
I tried getting a crude calculation of lives saved if use of the vaccine was done for all 14-26y women in Lebanon...but we really lack good data on HPV types and cervical cancer incidence (WHO estimates 260 cases and 130 deaths/y, national cancer registry 10 cases or so, ... really vague). We definitely need better reporting, and more research on it too.
Ok this is very very crude so don't quote me

...
Total 14-26y women = 380,000
Cost per vaccine = $300
>>>Total cost = $114 million
Minimum coverage duration for group = 5y
Annual mortality from Cervical cancer = 130 (WHO estimate)
>>>Deaths avoided per year = 130 x .70 = 91
>>>>Lives saved in 5y = 455
Cost per life saved = $114 million / 455 = $250,000.
Not to put a price on a human life, but yeah it probably is worth more than that in cost-benefit terms. Of course this is with the limited data we have, and considering that the only cost is the vaccine itself (not all materials, etc.).
I think $114million can be better invested elsewhere, but yeah if we manage to get some sort of mass subsidization one day from donors, might be worthwhile, especially since the Pap screening is totally not working out right.